** Medical equipment maker Haemonetics' HAE.N shares fall 8.3% to $65.3 to touch an over 2-1/2 year low
** Co cuts its sales growth forecast for fiscal 2025 to 3%-5% from 5%-8%
** Co reports Q3 revenue of $349 million, missing analyst estimates of $353 million - data compiled by LSEG
** Co posts adj Q3 profit of $1.19 per share, beating analyst estimates of $1.17 per share - LSEG
** Shares are down ~17% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。